MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-CH-01-0004232
Preet Remedies Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹62.83 Cr
▲ 18% YoY
Net profit · FY 2025
₹29.21 Lakh
Net margin 0.5%
EBITDA · FY 2025
₹4.3 Cr
EBITDA margin 6.8%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹7.2 Cr
Issued & subscribed
Open charges
₹19.65 Cr
Satisfied ₹67.7 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
36
Provident fund records
About Preet Remedies Limited
Data last updated:
Preet Remedies Limited is a public limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 February 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24230CH2005PLC027954. Its GSTIN is 02AADCP4799B2ZJ (Himachal Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹7.2 Cr. It was formerly known as Preet Remedies Private Limited. It is led by directors including Sanjeev Kumar (Managing Director) and Abhishek Rana.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 194 – 195 Third Floor Industrial Area Phase II, Chandigarh, India – 160002.
As per the financials filed for FY 2025, the company reported a revenue of ₹62.83 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹29.21 Lakh (net margin 0.5%) and EBITDA of ₹4.3 Cr (EBITDA margin 6.8%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 2% over five years.
The company has about 36 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Preet Remedies. As per MCA filings, the company has open charges of ₹19.65 Cr and satisfied charges of ₹67.7 Cr on record. Court records list 49 cases involving the company, including 21 filed by the company and 28 filed against it; 19 cases are pending. The company has 8 deals on record (6 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹80 Lakh; the latest was in November 2024. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Cooper Pharma Limited with revenue of ₹63.28 Cr. The company has 19 MSME Form 1 returns on record between 2018 and 2023, listing 4,869 overdue payments to 15 micro and small suppliers.
Preet Remedies Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0004232). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website preetremedies.com.
Company details
CIN U24230CH2005PLC027954
Registration Number 027954
Incorporation Date 10 February 2005
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-CH-01-0004232
CIN history
Preet Remedies has one previous CIN (Corporate Identification Number): U24230CH2005PTC027954. The current CIN is U24230CH2005PLC027954, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230CH2005PLC027954 | Current |
| U24230CH2005PTC027954 | Previous |
Recognitions & Rankings of Preet Remedies
Contact details
Preet Remedies Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 194 – 195 Third Floor Industrial Area Phase II, Chandigarh, India – 160002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Preet Remedies Limited, buy the company report.
Comprehensive company report
Preet Remedies Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Preet Remedies operates one associated brand: Preet Remedies. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides contract manufacturing for pharmaceutical drugs and products globally. | preetremedies.com |
Business activity
The main business activity of Preet Remedies is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Preet Remedies Limited, buy the company report.
Financials of Preet Remedies Limited
FY 2025 filings availablePreet Remedies Limited reported revenue of ₹62.83 Cr (up 18% YoY) for FY 2025.
Revenue · FY 2025
₹62.83 Cr ▲ 18%
Net profit · FY 2025
₹29.21 Lakh margin 0.5%
EBITDA · FY 2025
₹4.3 Cr margin 6.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 18%
3 years · compounded
▼ 7%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 5%
5 years · compounded
▲ 20%
Revenue rose 18% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.3 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹29.21 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.8% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Preet Remedies Limited, buy the company report.
Board of directors of Preet Remedies Limited
Preet Remedies has 6 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhishek Rana Also directs: Dancing Zorba Eco Farms LLP | Director | 29 Jan 2024 | 2 Years 9 Months | Current |
| Sanjay Dhir | Director | 01 May 2009 | 17 Years 6 Months | Current |
| Sanjeev Kumar Also directs: Zenlabs Ethica Limited, Oasis Pharma and Phytomolecules Private Limited, Ultra Chiron Healthcare Private Limited and 3 more | Managing Director | 15 Mar 2005 | 21 Years 7 Months | Current |
| Hitesh Popatlal Oswal | Director | 25 Sep 2020 | 6 Years 1 Months | Current |
| Prasanna Kumar Rout Also directs: Signature Steriles India Private Limited | Director | 31 Mar 2024 | 2 Years 7 Months | Current |
| Vijendra Kumar Gupta | Director | 21 Feb 2025 | 1 Years 8 Months | Current |
Peer comparison
Preet Remedies Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cooper Pharma Limited | ₹63.28 Cr (FY 2024) | -1.0% | Delhi, India | |||
| Althea Pharma Private Limited | ₹63.27 Cr (FY 2024) | 14.0% | Vapi, Gujarat, India | |||
| Onyx Biotec Limited | ₹63.12 Cr (FY 2025) | 17.0% | Solan, Himachal Pradesh, India | |||
| Thinq Pharma-Cro Limited | ₹62.89 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Preet Remedies Limitedthis company | ₹62.83 Cr (FY 2025) | ₹29.21 Lakh | 0.5% | 18.0% | 36 | Chandigarh, India |
| Sri Gayathri Drugs Private Limited | ₹62.48 Cr (FY 2025) | 15.0% | Hyderabad, Telangana, India | |||
| Shamshree Lifesciences Limited | ₹62.27 Cr (FY 2025) | 10.0% | Chandigarh, India | |||
| Cian Healthcare Limited | ₹62.14 Cr (FY 2024) | -10.0% | Pune, Maharashtra, India | |||
| Enanti Labs Private Limited | ₹62.07 Cr (FY 2025) | -14.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Preet Remedies Limited, buy the company report.
Auditor
Preet Remedies Limited is audited by Vijay Darji and Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vijay Darji and Associates | FY 2022 | 118614W |
Shareholding
The shareholding of Preet Remedies Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Preet Remedies Limited, buy the company report.
Charges & borrowings
Open charges
₹19.65 Cr
Satisfied charges
₹67.7 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Apr 2025 | 101087763 | Others | ₹18 Cr | Open | |
| 24 Aug 2022 | 100650534 | Hdfc Bank Limited | ₹1.37 Cr | Open | |
| 07 Feb 2009 | 10145251 | Deputy Director of Industries | ₹28.39 Lakh | Open | |
| 13 Dec 2024 | 101033340 | Canara Bank | ₹5 Cr | Satisfied | |
| 13 Dec 2024 | 101033350 | Canara Bank | ₹10 Cr | Satisfied |
To see the full charge records of Preet Remedies Limited, buy the company report.
Total charge records: 19 View all charges
Deals & funding
Preet Remedies Limited has 8 deals on record (6 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹80 Lakh; the latest was in November 2024.
Total deals
8
Secondary share transfers
6
Rights issue
1
Funding round
1
Disclosed funding
₹80 Lakh
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2024 | Funding round | ₹80 Lakh | Investors: Quixotic Pharma Private Limited |
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jun 2021 | Rights issue | ₹4 Cr | Investors: an individual |
| Dec 2020 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Aug 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Preet Remedies Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Preet Remedies Limited has 49 court cases on record: 21 filed by Preet Remedies, 28 filed against it. 19 cases are pending and 30 are disposed.
Total cases
49
Filed by the company
21
Filed against the company
28
Pending
19
Disposed
30
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 26 | 6 | 6 |
| District courts | 22 | 21 | 13 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 49)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Sun Pharmaceutical Industries Ltd. | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Glenmark Pharmaceuticals Ltd | Disposed |
| Bombay High Court | Court case (COMIP) | Filed against the company by Glenmark Pharmaceuticals Ltd | Disposed |
| Bombay High Court | Court case (S) | Filed against the company by Serum Institute of India Ltd | Disposed |
| District court, BAGALKOT, Karnataka | Criminal complaint | Filed against the company by The State/Drugs Inspector,Bagalkote-1 | Pending |
To see the full case history of Preet Remedies Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Preet Remedies Limited has 19 MSME Form 1 returns on record between 2018 and 2023, listing 4,869 overdue payments to 15 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 15)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Jasco Paper Products | |||
| Balasundari Industries | |||
| Preet Packaging Solutions | |||
| Saroj Packaging | |||
| Ganpati Additives Private Limited |
To see the full MSME payment records of Preet Remedies Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Preet Remedies has 2 associated companies. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.
2
Associated companies
Employees & EPFO
Preet Remedies Limited has a workforce of 36 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
36
Active EPFO establishments
1
Employee growth
-10%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 36 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Preet Remedies Limited, buy the company report.
GST
Preet Remedies has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AADCP4799B2ZJ | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Preet Remedies Limited, buy the company report.
Recent activity
Preet Remedies Limited has 24 board changes on record since 2005: 6 appointments and 18 cessations. The latest: Vijendra Kumar Gupta ceased to be Additional Director on 29 Sep 2025.
AGM
Preet Remedies Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Vijendra Kumar Gupta ceased to be Additional Director.
Charges
A charge with Others of Rs. 18.00 Cr registered on 11 Apr 2025 with Charge ID 101087763 was modified on 15 May 2025.
Charges
A charge registered on 13 Dec 2024 via Charge ID 101033340 with Canara Bank was fully satisfied on 08 May 2025.
Charges
A charge registered on 13 Dec 2024 via Charge ID 101033350 with Canara Bank was fully satisfied on 08 May 2025.
Charges
A charge with Others amounted to Rs. 18.00 Cr with Charge ID 101087763 was registered on 11 Apr 2025.
Filing
Preet Remedies Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Appointed
Vijendra Kumar Gupta was appointed as Director.
Charges
A charge registered on 18 Jul 2016 via Charge ID 100044296 with Hdfc Bank Limited was fully satisfied on 09 Jan 2025.
Charges
A charge with Canara Bank amounted to Rs. 5.00 Cr with Charge ID 101033340 was registered on 13 Dec 2024.
Charges
A charge with Canara Bank amounted to Rs. 10.00 Cr with Charge ID 101033350 was registered on 13 Dec 2024.
Ceased
Abhishek Rana ceased to be Additional Director.
59 earlier events are in the company report.
Frequently asked questions
Preet Remedies is an active public limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 February 2005 (21+ years old) and is registered under CIN U24230CH2005PLC027954.
Preet Remedies has 6 current directors:
- Sanjeev Kumar - Managing Director
- Abhishek Rana - Director
- Sanjay Dhir - Director
- Hitesh Popatlal Oswal - Director
- Prasanna Kumar Rout - Director
- Vijendra Kumar Gupta - Director
The latest financial statements of Preet Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Preet Remedies is 02AADCP4799B2ZJ, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Preet Remedies is U24230CH2005PLC027954. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Preet Remedies has 49 court cases on record: 21 filed by the company and 28 filed against it. 19 are pending. Most are in the high courts.
Preet Remedies was incorporated on 10 February 2005, making it 21+ years old. It is registered with the Registrar of Companies, Chandigarh.
Preet Remedies has 8 deals on record (6 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹80 Lakh; the latest was in November 2024.
The peers of Preet Remedies by revenue are Cooper Pharma Limited, Althea Pharma Private Limited, Onyx Biotec Limited, Thinq Pharma-Cro Limited, Sri Gayathri Drugs Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vijendra Kumar Gupta ceased to be Additional Director on 29 Sep 2025. Vijendra Kumar Gupta was appointed as Director on 21 Feb 2025. Abhishek Rana ceased to be Additional Director on 29 Sep 2024. Preet Remedies has 24 board changes on record in total.
Yes, Preet Remedies is registered as a medium enterprise under Udyam registration (number: UDYAM-CH-01-0004232).
Preet Remedies has 19 MSME Form 1 returns on record between 2018 and 2023, listing 4,869 overdue payments to 15 micro and small suppliers. The latest return was filed on 30 Jan 2024.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages